Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher K Rayner

Showing results (231-240 of 251) with videos related to

Pageof 26
Sort By:
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes Care|July 10, 2013
The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically illMichael Y Lee, Jonathan D Fraser, Marianne J Chapman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinomaAmanda Huoy Wen Lim, Nimit Singhal, Dylan Bartholomeusz, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes Care|November 10, 2020
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821Christopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes Care|May 31, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled TrialChristopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrationsKaren L Jones, Lian Q Huynh, Seva Hatzinikolas, et al.
Pageof 26

Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.
Diabetes Care|July 10, 2013
The effect of exogenous glucose-dependent insulinotropic polypeptide in combination with glucagon-like peptide-1 on glycemia in the critically illMichael Y Lee, Jonathan D Fraser, Marianne J Chapman, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Igie : Innovation, Investigation and Insights|February 6, 2026
Outcomes of phosphorus-32 microparticle intratumoral implantation added to chemotherapy in patients with metastatic pancreatic adenocarcinomaAmanda Huoy Wen Lim, Nimit Singhal, Dylan Bartholomeusz, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes Care|November 10, 2020
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821Christopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes Care|May 31, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled TrialChristopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes, Obesity & Metabolism|January 7, 2020
Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrationsKaren L Jones, Lian Q Huynh, Seva Hatzinikolas, et al.
Pageof 26